WA
EW icon

WP Advisors’s Edwards Lifesciences EW Stock Holding History

WP Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-552
Closed -$352 – 95
2019
Q1 		$352 Buy
+552
New +$31.5K 0.04% 143
2018
Q4 		– Sell
-552
Closed -$32K – 120
2018
Q3 		$32K Hold
552
– – 0.03% 152
2018
Q2 		$27K Buy
+552
New +$25.8K 0.03% 166

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

WP Advisors's EW Position: Q2 2019 in Review

WP Advisors sold out of Edwards Lifesciences (EW) in Q2 2019, closing a stake of 552 shares — an estimated $352 sold.

WP Advisors first reported a position in EW in Q2 2018 and held it in 3 quarters. The position peaked at $32K in Q3 2018. 921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

  • WP Advisors reported no remaining Edwards Lifesciences position as of Q2 2019 after selling out during the quarter.
  • WP Advisors sold 552 Edwards Lifesciences shares in Q2 2019, an estimated $352.
  • WP Advisors first reported a position in Edwards Lifesciences in Q2 2018 and held it in 3 quarters.
  • WP Advisors's Edwards Lifesciences position peaked at $32K in Q3 2018.
  • 921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on WP Advisors's 13F filing for Q2 2019, filed 23 Jul 2019.